BlackRock’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,231,552
| Closed | -$28.4M | – | 5325 |
|
|
2020
Q4 | $28.4M | Sell |
1,231,552
-773,808
| -39% | -$17.9M | ﹤0.01% | 2762 |
|
|
2020
Q3 | $20.4M | Buy |
2,005,360
+559,017
| +39% | +$5.69M | ﹤0.01% | 2782 |
|
|
2020
Q2 | $21.6M | Buy |
1,446,343
+312,364
| +28% | +$4.65M | ﹤0.01% | 2705 |
|
|
2020
Q1 | $13.8M | Buy |
1,133,979
+422,205
| +59% | +$5.15M | ﹤0.01% | 2766 |
|
|
2019
Q4 | $11.3M | Buy |
711,774
+267,040
| +60% | +$4.23M | ﹤0.01% | 3148 |
|
|
2019
Q3 | $5.46M | Buy |
444,734
+344,734
| +345% | +$4.23M | ﹤0.01% | 3423 |
|
|
2019
Q2 | $1.32M | Buy |
+100,000
| New | +$1.32M | ﹤0.01% | 3869 |
|